OPEN END TURBO PUT-OPTIONSSCHEIN MIT SL - STRYKER CORP. Stock

Certificat

DE000SV5D718

Real-time Boerse Frankfurt Warrants 06:54:28 2024-06-20 am EDT
0.62 EUR 0.00% Intraday chart for OPEN END TURBO PUT-OPTIONSSCHEIN MIT SL - STRYKER CORP.
Current month-17.33%
1 month-20.51%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-06-20 0.62 0.00%
24-06-19 0.62 -6.06%
24-06-18 0.66 -4.35%
24-06-17 0.69 -1.43%
24-06-14 0.7 -1.41%

Real-time Boerse Frankfurt Warrants

Last update June 20, 2024 at 06:54 am EDT

More quotes

Static data

Product typeKnock-Out with Stop Loss
Buy / SellPUT
Underlying STRYKER CORPORATION
IssuerLogo Issuer Société Générale Société Générale
WKN SV5D71
ISINDE000SV5D718
Date issued 2023-04-21
Strike 419.6 $
Maturity Unlimited
Parity 100 : 1
Emission price 1.06
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 1.56
Lowest since issue 0.52
Spread 0.04
Spread %6.06%

Company Profile

Stryker Corporation is one of the world's leaders in designing, manufacturing, and selling orthopedic equipments. Net sales break down by family of products as follows: - surgical equipments and neurotechnology products (57.5%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipments, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment; - orthopedic implants (42.5%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants. At the end of 2022, the group had 48 production sites worldwide. Net sales are distributed geographically as follows: the United States (73.9%), Europe/Middle East/Africa (12.7%), Asia/Pacific (10.2%) and other (3.2%).
Sector
-
More about the company

Ratings for Stryker Corporation

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Stryker Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
348.7 USD
Average target price
372.9 USD
Spread / Average Target
+6.96%
Consensus